Anti-PLA1A/ PS-PLA1/ PSPLA1 functional antibody

Anti-PLA1A/ PS-PLA1/ PSPLA1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to PLA1A/PLA1A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1189-Ab-1/ GM-Tg-hg-SE1189-Ab-2Anti-Human PLA1A monoclonal antibodyHuman
GM-Tg-rg-SE1189-Ab-1/ GM-Tg-rg-SE1189-Ab-2Anti-Rat PLA1A monoclonal antibodyRat
GM-Tg-mg-SE1189-Ab-1/ GM-Tg-mg-SE1189-Ab-2Anti-Mouse PLA1A monoclonal antibodyMouse
GM-Tg-cynog-SE1189-Ab-1/ GM-Tg-cynog-SE1189-Ab-2Anti-Cynomolgus/ Rhesus macaque PLA1A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1189-Ab-1/ GM-Tg-felg-SE1189-Ab-2Anti-Feline PLA1A monoclonal antibodyFeline
GM-Tg-cang-SE1189-Ab-1/ GM-Tg-cang-SE1189-Ab-2Anti-Canine PLA1A monoclonal antibodyCanine
GM-Tg-bovg-SE1189-Ab-1/ GM-Tg-bovg-SE1189-Ab-2Anti-Bovine PLA1A monoclonal antibodyBovine
GM-Tg-equg-SE1189-Ab-1/ GM-Tg-equg-SE1189-Ab-2Anti-Equine PLA1A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1189-Ab-1/ GM-Tg-hg-SE1189-Ab-2; GM-Tg-rg-SE1189-Ab-1/ GM-Tg-rg-SE1189-Ab-2;
GM-Tg-mg-SE1189-Ab-1/ GM-Tg-mg-SE1189-Ab-2; GM-Tg-cynog-SE1189-Ab-1/ GM-Tg-cynog-SE1189-Ab-2;
GM-Tg-felg-SE1189-Ab-1/ GM-Tg-felg-SE1189-Ab-2; GM-Tg-cang-SE1189-Ab-1/ GM-Tg-cang-SE1189-Ab-2;
GM-Tg-bovg-SE1189-Ab-1/ GM-Tg-bovg-SE1189-Ab-2; GM-Tg-equg-SE1189-Ab-1/ GM-Tg-equg-SE1189-Ab-2
Products NameAnti-PLA1A monoclonal antibody
Formatmab
Target NamePLA1A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PLA1A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1189-Ag-1Recombinant multi-species PLA1A/ PS-PLA1/ PSPLA1 protein


    Target information

    Target IDGM-SE1189
    Target NamePLA1A
    Gene ID51365,85031,85311,712705,515900,100070985
    Gene Symbol and SynonymsPLA1A,PS-PLA1,PSPLA1
    Uniprot AccessionQ53H76,P97535,Q5E9H0
    Uniprot Entry NamePLA1A_HUMAN,PLA1A_RAT,PLA1A_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000144837
    Target ClassificationN/A

    The target: PLA1A, gene name: PLA1A, also named as PS-PLA1, PSPLA1. The protein encoded by this gene is a phospholipase that hydrolyzes fatty acids at the sn-1 position of phosphatidylserine and 1-acyl-2-lysophosphatidylserine. This secreted protein hydrolyzes phosphatidylserine in liposomes. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.